Structural Biology and Molecular Pharmacology of Voltage-gated Ion Channels
Overview
Molecular Biology
Authors
Affiliations
Voltage-gated ion channels (VGICs), including those for Na, Ca and K, selectively permeate ions across the cell membrane in response to changes in membrane potential, thus participating in physiological processes involving electrical signalling, such as neurotransmission, muscle contraction and hormone secretion. Aberrant function or dysregulation of VGICs is associated with a diversity of neurological, psychiatric, cardiovascular and muscular disorders, and approximately 10% of FDA-approved drugs directly target VGICs. Understanding the structure-function relationship of VGICs is crucial for our comprehension of their working mechanisms and role in diseases. In this Review, we discuss how advances in single-particle cryo-electron microscopy have afforded unprecedented structural insights into VGICs, especially on their interactions with clinical and investigational drugs. We present a comprehensive overview of the recent advances in the structural biology of VGICs, with a focus on how prototypical drugs and toxins modulate VGIC activities. We explore how these structures elucidate the molecular basis for drug actions, reveal novel pharmacological sites, and provide critical clues to future drug discovery.
Preferential allosteric modulation of Otop1 channels by small molecule compounds.
Kong X, Sun J, Zhang H, Yin Y, Liang X, Chen Y Commun Biol. 2025; 8(1):314.
PMID: 40011703 PMC: 11865470. DOI: 10.1038/s42003-025-07775-9.
Wang J, Du B, Zhang X, Qu X, Yang Y, Yang Z Nat Plants. 2025; .
PMID: 39979428 DOI: 10.1038/s41477-025-01923-z.
The small molecule Ebio3 inactivates the KCNQ2 channel without blocking the pore.
Nat Chem Biol. 2025; .
PMID: 39971774 DOI: 10.1038/s41589-025-01853-z.
Inactivation of CaV1 and CaV2 channels.
Limpitikul W, Dick I J Gen Physiol. 2025; 157(2).
PMID: 39883005 PMC: 11781272. DOI: 10.1085/jgp.202313531.
Toxins from Animal Venom-A Rich Source of Active Compounds with High Pharmacological Potential.
Lyukmanova E, Shenkarev Z Toxins (Basel). 2024; 16(12.
PMID: 39728770 PMC: 11728658. DOI: 10.3390/toxins16120512.